EMA Authorised: Genvoya (elvitegravir;cobicistat;emtricitabine;tenofovir alafenamide) — Gilead Sciences Ireland UC

View source ↗

Summary

The EMA authorised Genvoya, a fixed-dose combination antiretroviral therapy for HIV infection, manufactured by Gilead Sciences Ireland UC. This marks EU authori…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Genvoya (elvitegravir; cobicistat; emtricitabine; tenofovir alafenamide)

Snippet

Status: Authorised. Therapeutic area: HIV Infections. MAH: Gilead Sciences Ireland UC. Decision date: 03/10/2022